2022 Annual Meeting | C147 - Neuromyelitis Optica Spectrum Disorders

Date Thursday 04/07/22

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Dean M. Wingerchuk, MD, FAAN

Topic(s) Multiple Sclerosis

Learning Objectives Upon completion of this course, participants should be able to describe clinical presentation of NMOSD; discuss diagnostic criteria for NMOSD; compare and contrast clinical features of NMOSD with common diseases that mimic NMOSD; be familiar with the imaging characteristics of NMOSD; and discuss approved treatment options for NMOSD.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:45 AM PDT	Speaker	NMOSD: Diagnostic Issues Cristina Valencia Sanchez, MD
07:00 AM - 07:00 AM PDT	Speaker	Walk-in Slides Dean M. Wingerchuk, MD, FAAN
07:45 AM - 08:30 AM PDT	Speaker	NMOSD: Treatment Issues Dean M. Wingerchuk, MD, FAAN
08:30 AM - 09:00 AM PDT	Speaker	Case-Based Discussions Dean M. Wingerchuk, MD, FAAN, Cristina Valencia Sanchez, MD

Faculty Disclosures
Dean M. Wingerchuk, MD, FAAN	Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TTY Biopharm. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Biopharm. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Cristina Valencia Sanchez, MD	Dr. Valencia Sanchez has nothing to disclose.